SPA
ACLX

Sherbrooke Park Advisers’s Arcellx ACLX Stock Holding History

Sherbrooke Park Advisers’s Portfolio ACLX Stock Details ACLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,805
Closed -$292K – 572
2024
Q4 		$292K Buy
+3,805
New +$329K 0.09% 416

Other funds holding ACLX

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

Sherbrooke Park Advisers's ACLX Position: Q1 2025 in Review

Sherbrooke Park Advisers sold out of Arcellx (ACLX) in Q1 2025, closing a stake of 3,805 shares — an estimated $292K sold.

Sherbrooke Park Advisers first reported a position in ACLX in Q4 2024 and held it in 1 quarter. The position peaked at $292K in Q4 2024. 197 funds tracked by Wall St. Rank hold ACLX as of Q1 2025.

  • Sherbrooke Park Advisers reported no remaining Arcellx position as of Q1 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 3,805 Arcellx shares in Q1 2025, an estimated $292K.
  • Sherbrooke Park Advisers first reported a position in Arcellx in Q4 2024 and held it in 1 quarter.
  • Sherbrooke Park Advisers's Arcellx position peaked at $292K in Q4 2024.
  • 197 funds tracked by Wall St. Rank held Arcellx as of Q1 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q1 2025, filed 15 May 2025.